Luciana Costa Faria

Luciana Costa Faria

Auto-generated profile, based on publicly available information

Luciana Costa Faria

Universidade Federal de Minas Gerais

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2020 in Journal of Oncology
Verified
Journal Article
Open access
PDPaulo H. C. Diniz
Paulo H. C. Diniz
SSSerena D. C. Silva
Serena D. C. Silva
PVPaula V. T. Vidigal
Paula V. T. Vidigal
MXMarcelo A. P. Xavier
Marcelo A. P. Xavier
CLCristiano X. Lima
Cristiano X. Lima
TFTeresa Cristina Abreu Ferrari
Teresa Cristina Abreu Ferrari
Expression of MAPK and PI3K/AKT/mTOR Proteins according to the Chronic Liver Disease Etiology in Hepatocellular Carcinoma: Aims. Chronic liver disease (CLD) of different etiologies leads to hepatocellular carcinoma (HCC) by multiple mechanisms that may be translated into clinicopathological differences. We evaluated the tissue expression of the MAPK and PI3K/Akt/mTOR pathway proteins and their association with long-term outcome and other parameters, according to the etiology of the CLD, in HCC patients. Methods. Clinicopathological data from 80 patients who underwent orthotopic liver transplantation for HCC treatment in a Brazilian referral center were compared according to CLD etiology. Event (tumor recurrence or death from any cause) occurrence and event-free survival (EFS) were analyzed. Pathway protein expression was assessed by immunohistochemistry (IHQ) in both tumor and underlying cirrhosis and by RT-PCR in tumor tissue. Results. Strong expression (SE) of KRAS was more frequent in tumors arising from viral (26.8%) than the nonviral group of liver disease (7.7%, ) and also than cirrhotic parenchyma (0%, ). SE of PI3K was more frequent in tumor than in cirrhosis ( , ), without differences in its tumor expression among etiologic groups . mRNA of ERK, PI3K, and BRAF was expressed in the tumor, without differences between CLD etiologies, and there was no association with IHQ findings. Older age and microvascular invasion (MIV) were the only parameters independently associated with the event. MIV was also associated with shorter EFS. Conclusions. Hepatitis B and C virus can lead to HCC by different mechanisms compared with nonviral hepatopathy. KRAS and PI3K may have a role in carcinogenesis. The prognostic and therapeutic implications need to be investigated.

1 July 2021 in Annals of Hepatology
Verified
Journal Article
Open access
GSGenario Santos
Genario Santos
EFEstela Regina Ramos Regina Ramos Figueira
Estela Regina Ramos Regina Ramos Figueira
LDLuiz Augusto Carneiro D’aLbuquerque
Luiz Augusto Carneiro D’aLbuquerque
PLPaulo Bittencourt Lisboa
Paulo Bittencourt Lisboa
MAMarcio Dias de Almeida
Marcio Dias de Almeida
RPRaymundo Paraná
Raymundo Paraná
Little is known about the etiology of acute liver failure (ALF) in Latin America. The objective of this paper is to investigate the main etiologies of ALF in Brazil, including Drug Induced Liver Injury (DILI) using stringent causality criteria. All the cases of individuals who underwent liver transplantation (LT) in 12 centers in Brazil for ALF were reviewed. When DILI was stated as the cause of ALF, causality criteria were applied on site by the main investigator in order to rule out other etiologies. 325 individuals had ALF mainly for unknown reasons (34%), DILI (27%) and AIH (18%). Reassessment of the 89 cases of DILI, using stringent causality criteria, revealed that in only 42 subjects could DILI be confirmed as the cause of ALF. Acetaminophen (APAP) toxicity (n = 3) or DILI due to herbal and dietary supplements (HDS) (n = 2) were not commonly observed. Undetermined etiology and DILI are the main causes of ALF in Brazil. However, APAP toxicity and DILI due to HDS are mostly uncommon.

5 June 2020 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
DTDaniela Oliveira de Lima Taranto
Daniela Oliveira de Lima Taranto
TGThais Cristine Moura Guimarães
Thais Cristine Moura Guimarães
CCClaudia A. Couto
Claudia A. Couto
ACAna Lúcia Cândido
Ana Lúcia Cândido
RARosana Correa Silva Azevedo
Rosana Correa Silva Azevedo
LFLuciana C. Faria
Luciana C. Faria
Polycystic ovary syndrome (PCOS) is a recognized risk factor for nonalcoholic fatty liver disease (NAFLD). The aims of this study were to investigate the prevalence and factors associated with NAFLD in women with PCOS and evaluate noninvasive indices of hepatic fibrosis in patients with PCOS and NAFLD. Patients with PCOS (n = 87) and women without PCOS (n = 40; controls) were included. NAFLD was diagnosed by abdominal ultrasonography after exclusion of alcohol consumption and viral or autoimmune liver disease. Anthropometric, clinical and metabolic variables, homeostasis model assessment of insulin resistance (HOMA-IR) index, lipid accumulation product (LAP), FIB-4 index, NAFLD score, and transient elastography (TE; FibroScan) were obtained in subsets of patients with PCOS and NAFLD. A total of 87 patients with PCOS were included (mean age: 34.4 ± 5.7 years, mean body mass index [BMI]: 34.7 ± 4.7 kg/m 2 ). NAFLD was present in 67 (77.0%) patients with PCOS versus 21 of 40 (52.5%) controls (p = 0.005). Women with PCOS and liver steatosis, compared with their NAFLD-free counterparts, had higher values of BMI, waist circumference, triglycerides, total cholesterol, alanine and aspartate aminotransferases, and γ-glutamyltransferase, along with higher frequencies of obesity, metabolic syndrome, and insulin resistance. NAFLD was independently associated with waist circumference, serum triglycerides, and alanine aminotransferase levels. The FIB-4 index was not compatible with advanced fibrosis in any of the evaluated patients, while NAFLD score and TE were compatible with advanced liver fibrosis in 1 of 26 (3.8%) and 3 of 25 (12%) patients, respectively. Women with PCOS had a high risk of NAFLD, and a combination of both was associated with central obesity, dyslipidemia, insulin resistance, and metabolic syndrome. Noninvasive methods suggested low rates of severe hepatic fibrosis in Brazilian women with PCOS. Arch Endocrinol Metab. 2020;64(3):235-42.

1 January 2009 in Clinics
Verified
Journal Article
Open access
PDF file
LFLuciana C. Faria
Luciana C. Faria
CRClarissa C. Resende
Clarissa C. Resende
CCCláudia A. Couto
Cláudia A. Couto
OCOsvaldo F.M. Couto
Osvaldo F.M. Couto
LFLúcia P.C. Fonseca
Lúcia P.C. Fonseca
TFTeresa Cristina Abreu Ferrari
Teresa Cristina Abreu Ferrari
SEvERE anD pROLOngED cHOLESTaSIS cauSED by TRImETHOpRIm-SuLfamETHOxazOLE: a caSE REpORT doi: 10.1590/S1807-5932200900010001

1 January 2021 in Canadian Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
MNMateus Jorge Nardelli
Mateus Jorge Nardelli
PBPaulo Lisboa Bittencourt
Paulo Lisboa Bittencourt
GCGuilherme Grossi Lopes Cançado
Guilherme Grossi Lopes Cançado
LFLuciana Costa Faria
Luciana Costa Faria
CVCristiane Alves Villela-Nogueira
Cristiane Alves Villela-Nogueira
CCClaudia Alves Couto
Claudia Alves Couto
Background. Primary sclerosing cholangitis (PSC) is associated with a broad phenotypic spectrum in different populations from diverse ethnic and racial backgrounds. This study aimed to describe the clinical characteristics and outcomes of PSC in a multicenter cohort of patients from Brazil. Methods. Data from the Brazilian Cholestasis Study Group were retrospectively reviewed to assess demographic information and clinical characteristics of PSC, as well as the outcomes, such as transplantation‐free survival. Results. This cohort included 210 patients. After excluding 33 (15.7%) patients with PSC and overlap syndrome of autoimmune hepatitis, 177 (97 males, median age 33 (21–42) years) with clear‐cut PSC were eligible for this study. Most of the patients (n = 139, 78.5%) were symptomatic, and 104 (58.7%) had advanced PSC at the time of diagnosis. Concurrent inflammatory bowel disease was observed in 78 (58.6%) of the investigated patients (n = 133), and most of them had ulcerative colitis (n = 61, 78.2%). The 1‐ and 5‐year survival free of liver transplantation or death were 92.3 ± 2.1% and 66.9 ± 4.2%, respectively, and baseline advanced PSC, pruritus, and elevated bilirubin levels were independent risk factors for the composite adverse outcome. Females were significantly older and had lower bilirubin levels than males at baseline, but survival was not associated with sex. Approximately 12.4% (n = 22) of patients with PSC died, and 32.8% (n = 58) underwent liver transplantation at a median follow‐up time of 5.3 and 3.2 years. Conclusion. Multiethnic Brazilian PSC patients exhibited a less pronounced male predominance and a lower frequency of inflammatory bowel disease than Caucasians. Adverse outcomes were more frequent, probably due to advanced disease at baseline.

7 April 2020 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
LFLuciana C. Faria
Luciana C. Faria
AAAntônio Márcio F. Andrade
Antônio Márcio F. Andrade
CTCyntia G. M. C. Trant
Cyntia G. M. C. Trant
ALAgnaldo Soares Lima
Agnaldo Soares Lima
PMPedro A. B. Machado
Pedro A. B. Machado
MAMARCUS ANDRADE
MARCUS ANDRADE